1.
Bleomycin electrosclerotherapy (BEST) for the treatment of vascular malformations. An International Network for Sharing Practices on Electrochemotherapy (InspECT) study group report. Radiol Oncol. 2023;57(2):141-149. Accessed October 13, 2026. https://radioloncol.com/index.php/ro/article/view/4120